STEP-UP will test intensified radiotherapy for unresectable locally recurrent rectal cancer
The 30-patient STEP-UP study will assess severe toxicity after dose-escalated SBRT, hyperfractionated reirradiation or chemoradiotherapy for unresectable rectal recurrence.